HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Dynamic Advisor Solutions LLC

Dynamic Advisor Solutions LLC lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 1.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,746 shares of the company’s stock after selling 31 shares during the quarter. Dynamic Advisor Solutions LLC’s holdings in HCA Healthcare were worth $949,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Robbins Farley lifted its stake in HCA Healthcare by 20.0% in the first quarter. Robbins Farley now owns 5,927 shares of the company’s stock valued at $2,048,000 after buying an additional 987 shares during the last quarter. Stock Yards Bank & Trust Co. purchased a new stake in shares of HCA Healthcare during the first quarter worth approximately $394,000. Metropolis Capital Ltd purchased a new stake in shares of HCA Healthcare during the first quarter worth approximately $117,984,000. CVA Family Office LLC raised its stake in shares of HCA Healthcare by 13.3% during the first quarter. CVA Family Office LLC now owns 538 shares of the company’s stock worth $186,000 after purchasing an additional 63 shares during the last quarter. Finally, NorthCrest Asset Manangement LLC raised its stake in shares of HCA Healthcare by 6.2% during the first quarter. NorthCrest Asset Manangement LLC now owns 3,977 shares of the company’s stock worth $1,374,000 after purchasing an additional 231 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE HCA opened at $372.09 on Wednesday. The firm has a market capitalization of $89.51 billion, a P/E ratio of 16.54, a P/E/G ratio of 1.27 and a beta of 1.49. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The business’s 50-day simple moving average is $359.85 and its 200-day simple moving average is $333.79.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company’s revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company posted $5.36 EPS. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.77%. The ex-dividend date is Monday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.81%.

Insider Buying and Selling

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on HCA shares. Royal Bank Of Canada cut their price target on HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. Robert W. Baird reissued a “neutral” rating and issued a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Stephens raised HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Guggenheim initiated coverage on HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating for the company. Finally, Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Monday, April 28th. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $392.47.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.